Clinical importance of microbleeds in patients receiving IV thrombolysis

W Kakuda1, V N Thijs, M G Lansberg

  • 1Stanford Stroke Center, Stanford University Medical Center, Palo Alto, CA, USA. wkakuda@stanford.edu

Neurology
|October 26, 2005
PubMed
Abstract

Insights

Cerebral microbleeds (MBs) on gradient echo imaging do not significantly increase the risk of brain hemorrhage in stroke patients receiving IV tissue plasminogen activator (tPA) within 3 to 6 hours of symptom onset.

Area of Science:

  • Neurology
  • Radiology
  • Cardiovascular Research

Background:

  • Cerebral microbleeds (MBs) detected by gradient echo (GRE) imaging are a potential risk factor for hemorrhagic complications.
  • Intravenous tissue plasminogen activator (IV tPA) is a common treatment for acute ischemic stroke.

Purpose of the Study:

  • To investigate the association between baseline cerebral microbleeds (MBs) and hemorrhagic complications after IV tPA treatment in acute ischemic stroke patients.
  • To determine if pre-existing MBs increase the risk of symptomatic or asymptomatic hemorrhage following thrombolysis.

Main Methods:

  • Prospective evaluation of acute ischemic stroke patients treated with IV tPA within 3-6 hours of symptom onset.
  • MRI scans including GRE imaging performed before, during, and after IV tPA treatment.
  • Comparison of hemorrhagic complication rates in patients with and without baseline MBs.

Main Results:

  • MBs were identified in 15.7% of patients on baseline GRE imaging.
  • No significant difference in symptomatic or asymptomatic hemorrhagic complications was observed between patients with and without baseline MBs.
  • Patients with baseline MBs had a 0% rate of symptomatic intracerebral hemorrhage compared to 11.9% in those without MBs.

Conclusions:

  • The presence of cerebral microbleeds on GRE imaging does not substantially elevate the risk of brain hemorrhage after IV tPA administration.
  • This finding suggests that IV tPA can be safely administered in stroke patients with MBs detected on baseline GRE imaging within the specified time window.

Related Concept Videos

Anticoagulant Drugs: Low-Molecular-Weight Heparins01:30

Anticoagulant Drugs: Low-Molecular-Weight Heparins

Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care01:29

Venous Thrombosis III: Interprofessional Care

Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care01:29

Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care

Diagnosing Pulmonary EmbolismDiagnosing pulmonary embolism (PE) involves clinical assessment and advanced imaging tests. The preferred diagnostic tool is the spiral (helical) CT scan or CT angiography (CTA), which uses intravenous contrast media to visualize the pulmonary vasculature and identify emboli.A ventilation-perfusion (V/Q) scan is an alternative for patients unable to receive contrast media. This scan includes both perfusion and ventilation scanning. Perfusion scanning involves...
Ischemic Stroke ll: Pathophysiology01:15

Ischemic Stroke ll: Pathophysiology

An ischemic stroke occurs when a cerebral blood vessel becomes obstructed, most often by a thrombus or embolus, interrupting the delivery of oxygen and glucose to brain tissue. Because neurons rely on continuous aerobic metabolism, energy failure begins within minutes of reduced perfusion. The region receiving the least blood flow becomes the infarct core, an area of irreversible cellular death. Surrounding this core lies the penumbra, a zone of hypoperfused but still viable tissue that is...
Hemorrhagic Stroke l: Introduction01:17

Hemorrhagic Stroke l: Introduction

A hemorrhagic stroke is an acute neurological event that occurs when a weakened cerebral blood vessel ruptures, allowing blood to accumulate within or around the brain. The sudden release of blood forms a focal hematoma that increases intracranial pressure, displaces neural tissue, and can obstruct cerebrospinal fluid pathways. These effects may be compounded by intraventricular extension of the hemorrhage, cerebral edema, or compression of adjacent structures, all of which contribute to...
Hemorrhagic Stroke ll: Pathophysiology01:29

Hemorrhagic Stroke ll: Pathophysiology

A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...